https://www.novartis.com/ph-en/
2024-03-21T13:56:07+08:00
daily
1.0
https://www.novartis.com/ph-en/media-library/sample-pdf
2022-06-30T12:53:32+08:00
daily
1.0
https://www.novartis.com/ph-en/media-library/what-pik3ca-and-why-it-important-you
2022-07-15T16:29:29+08:00
daily
1.0
https://www.novartis.com/ph-en/media-library/tuklasin-ang-lihim-sa-likod-ng-kanser-sa-suso
2022-07-15T16:30:48+08:00
daily
1.0
https://www.novartis.com/ph-en/media-library/see-what-lies-beneath-breast-cancer
2022-07-15T16:31:35+08:00
daily
1.0
https://www.novartis.com/ph-en/media-library/hindi-pare-pareho-ang-mga-uri-ng-kanser-sa-suso
2022-07-15T16:33:11+08:00
daily
1.0
https://www.novartis.com/ph-en/media-library/see-what-lies-beneath-breast-cancer-video
2022-07-15T16:34:32+08:00
daily
1.0
https://www.novartis.com/ph-en/media-library/pediatric-psoriasis
2022-07-15T16:47:09+08:00
daily
1.0
https://www.novartis.com/ph-en/media-library/2024-pncs-novartis-symposium
2024-02-22T10:42:43+08:00
daily
1.0
https://www.novartis.com/ph-en/page-not-found
2022-02-10T17:05:30+08:00
daily
1.0
https://www.novartis.com/ph-en/careers
2023-01-20T16:02:09+08:00
daily
1.0
https://www.novartis.com/ph-en/about/country-leadership-team
2023-10-12T13:45:06+08:00
daily
1.0
https://www.novartis.com/ph-en/patients-and-caregivers/novartis-commitment-patients-and-caregivers
2023-10-16T19:46:13+08:00
daily
1.0
https://www.novartis.com/ph-en/about/novartis-philippines
2024-03-11T10:44:13+08:00
daily
1.0
https://www.novartis.com/ph-en/esg/ethical-behavior
2021-12-15T16:45:05+08:00
daily
1.0
https://www.novartis.com/ph-en/esg/ethical-behavior/code-ethics
2021-12-15T16:40:43+08:00
daily
1.0
https://www.novartis.com/ph-en/esg/ethical-behavior/speakup
2022-03-11T18:49:06+08:00
daily
1.0
https://www.novartis.com/ph-en/about/contact
2023-10-09T15:40:08+08:00
daily
1.0
https://www.novartis.com/ph-en/about-us/contact-us/office-locations
2022-03-02T17:13:33+08:00
daily
1.0
https://www.novartis.com/ph-en/terms-use
2022-03-11T21:26:02+08:00
daily
1.0
https://www.novartis.com/ph-en/privacy-policy
2024-02-20T15:29:57+08:00
daily
1.0
https://www.novartis.com/ph-en/about-cookies
2022-03-02T17:13:33+08:00
daily
1.0
https://www.novartis.com/ph-en/news/news-archive
2023-03-10T21:23:27+08:00
daily
1.0
https://www.novartis.com/ph-en/news/media-contacts
2022-04-01T22:52:03+08:00
daily
1.0
https://www.novartis.com/ph-en/news/media-releases
2022-03-02T17:13:33+08:00
daily
1.0
https://www.novartis.com/ph-en/cookies
2022-03-02T17:13:33+08:00
daily
1.0
https://www.novartis.com/ph-en/privacy-notice-individuals-involved-adverse-event-medical-information-query-or-product-complaint
2022-03-15T16:20:43+08:00
daily
1.0
https://www.novartis.com/ph-en/website-privacy-policy
2022-04-01T22:40:50+08:00
daily
1.0
https://www.novartis.com/ph-en/coronavirus/novartis-ph-covid-19-initiatives
2022-03-15T19:02:50+08:00
daily
1.0
https://www.novartis.com/ph-en/patient-resources/breast-cancer
2024-02-22T10:49:41+08:00
daily
1.0
https://www.novartis.com/ph-en/patient-resources/psoriasis
2023-03-29T17:15:08+08:00
daily
1.0
https://www.novartis.com/ph-en/esg/financial-transparency-philippines
2023-08-24T11:11:24+08:00
daily
1.0
https://www.novartis.com/ph-en/patient-resources/unblocked-heart-health
2023-11-13T16:30:25+08:00
daily
1.0
https://www.novartis.com/ph-en/news
2022-04-12T19:24:28+08:00
daily
0.5
https://www.novartis.com/ph-en/about
2022-04-07T15:00:03+08:00
daily
0.5
https://www.novartis.com/ph-en/home
2024-03-21T13:56:07+08:00
daily
0.5
https://www.novartis.com/ph-en/esg
2022-04-01T21:30:33+08:00
daily
0.5
https://www.novartis.com/ph-en/patients-and-caregivers
2022-07-19T14:08:03+08:00
daily
0.5
https://www.novartis.com/ph-en/healthcare-professionals
2022-04-12T19:23:47+08:00
daily
0.5
https://www.novartis.com/ph-en/coronavirus
2022-03-16T19:24:57+08:00
daily
0.5
https://www.novartis.com/ph-en/patients-and-caregivers/patient-resources
2023-11-13T16:34:05+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-renews-partnership-st-lukes-medical-center-center-excellence-clinical-trials
2022-03-15T20:23:36+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-foundation-commemorates-world-leprosy-day-its-continued-efforts-go-last-mile-toward-elimination
2022-03-14T20:42:21+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-commends-publication-major-report-which-recommends-broad-use-dual-bronchodilators-treat-copd
2022-03-14T21:59:40+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-ranibizumab-receives-eu-approval-new-indication-ranibizumab-only-treatment-available-wide-range-cnv-conditions
2022-03-14T20:33:54+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-philippine-dermatological-society-form-partnership-provide-continuing-medical-education-psoriasis-diagnosis-and-management
2022-03-14T17:07:15+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-global-survey-shows-85-fear-blindness-only-33-have-regular-eye-examination
2022-03-15T17:09:36+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-partners-philippine-glaucoma-society-help-prevent-blindness-promote-regular-eye-exams
2022-03-14T22:14:31+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-partners-adb-swiss-embassy-hold-forum-achieving-universal-health-coverage-developing-countries
2022-03-14T14:39:46+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-secukinumab-first-and-only-il-17a-inhibitor-potentially-modify-course-psoriasis
2022-03-14T20:33:04+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-philippines-associates-celebrate-companys-21st-annual-community-partnership-day-through-volunteer-activities
2022-03-14T18:33:51+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-secukinumab-shows-sustained-improvements-signs-and-symptoms-both-and-psa-80-patients-3-years
2022-03-14T19:42:54+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/increased-awareness-organ-donation-key-saving-lives-filipinos-requiring-kidney-transplantation
2022-03-15T16:24:15+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/doh-novartis-gather-stakeholders-achieve-zero-leprosy-transmission-ph
2022-03-14T14:34:52+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-partners-local-diabetes-experts-enhance-primary-care-physicians-skills-diabetes-diagnosis-and-management
2022-03-14T15:33:11+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-philippine-heart-association-collaborate-enhance-local-cardiologists-skills-heart-failure-care
2022-03-14T17:52:23+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-philippine-college-chest-physicians-launch-copd-awareness-campaign
2022-03-15T14:23:50+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-partners-medical-experts-patient-group-raise-awareness-psoriasis
2022-03-15T20:40:40+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-promotes-awareness-dry-eye-syndrome-common-condition-among-internet-users
2022-03-15T17:06:54+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-foundation-joins-new-global-partnership-dedicated-accelerating-leprosy-eradication
2022-03-14T18:58:02+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-transform-study-confirms-strong-efficacy-and-significantly-reduced-infection-rate-everolimus-based-regimen-transplant-patients
2022-03-14T21:31:29+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-renews-partnership-philippine-heart-center-center-excellence-clinical-trials
2022-03-14T20:14:02+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-philippine-dermatological-society-form-alliance-increase-awareness-psoriasis
2022-03-14T17:04:42+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/experts-sound-alarm-over-countrys-dismally-low-number-deceased-kidney-donors
2022-03-15T19:57:06+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-adb-hold-forum-ceos-top-philippine-hospitals
2022-03-14T19:06:11+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/sandoz-philippines-names-new-country-head
2022-03-15T14:10:16+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-receives-aon-special-recognition-commitment-leadership
2022-03-15T18:30:18+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/sandoz-novartis-partner-specialists-hold-mental-health-law-forum
2022-03-14T18:54:18+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/learns-countrys-first-mobile-phone-based-leprosy-teleconsultation-system
2022-03-14T21:59:16+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-commits-help-strengthen-healthcare-system-support-uhc
2022-03-14T21:57:38+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/sandoz-philippines-hosts-its-first-ever-heart-mind-and-brain-summit
2022-03-15T13:59:15+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/kidney-transplant-recipient-shares-inspiring-story-launches-book-novartis-patient-forum
2022-03-15T15:17:19+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/sandoz-novartis-philippines-joins-international-womens-day-celebration-highlight-commitment-diversity-and-inclusion
2022-03-15T13:50:25+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-philippines-inaugurates-new-office-designed-foster-collaboration-innovation-and-work-flexibility
2022-03-16T15:49:33+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-partners-specialists-patient-group-celebrating-world-ankylosing-spondylitis-day
2022-03-14T16:39:01+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/docufilm-contest-launched-encourage-organ-donation-among-filipinos
2022-03-15T15:14:51+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-lowers-prices-its-hypertension-and-epilepsy-medicines-ph
2022-03-14T18:09:12+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/positive-results-from-novartis-five-year-verify-study-type-2-diabetes-demonstrate-long-term-clinical-benefits-early-combination-treatment-vildagliptin-and-metformin
2022-03-14T19:47:09+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-supports-global-partnership-stop-leprosy-transmission
2022-03-14T17:20:44+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/new-study-shows-early-combination-treatment-metformin-plus-vildagliptin-better-standard-care-newly-diagnosed-type-2-diabetes-patients
2022-04-01T22:49:19+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-extends-financial-assistance-2500-families-affected-taal-volcano-eruption
2022-03-15T16:29:31+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-philippines-actions-mitigate-covid-19-impact
2022-03-15T16:26:26+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/sandoz-novartis-philippines-announce-donation-hydroxychloroquine-doh
2022-03-15T13:31:22+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-donates-ppes-and-medicines-support-philippine-response-covid-19-pandemic
2022-03-28T22:31:47+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/covid-19-response-philippines-novartis-and-sandoz-contributions
2022-03-15T16:27:23+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-philippine-neurological-association-hold-virtual-media-briefing-easing-and-preventing-migraine-amid-covid-19-pandemic
2022-03-15T16:07:51+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/covid-19-response-philippines-novartis-contributions
2022-03-15T19:08:04+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-partners-de-la-salle-medical-and-health-sciences-institute-establish-center-excellence-clinical-trials
2022-03-14T14:46:35+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/sandoz-donates-medicines-philippine-red-cross-support-countrys-covid-19-response
2022-03-14T19:14:59+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-partners-international-agency-prevention-blindness-address-eye-screening-gaps
2022-03-14T15:26:03+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/local-study-shows-annual-productivity-costs-lost-due-migraine-disability-could-be-high-php41000-person
2022-04-01T23:03:45+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-contributed-php-8-billion-philippine-economy-2019
2022-03-14T19:39:51+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-renews-commitment-support-doh-goal-leprosy-free-philippines
2022-03-15T19:34:57+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/world-cancer-day-2021-novartis-lowers-prices-broad-range-cancer-medicines-help-filipino-patients
2022-03-15T14:18:04+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-partners-eye-specialists-promote-awareness-glaucoma-leading-cause-blindness-people-over-60
2022-03-15T20:34:59+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-executive-elected-chair-philippine-swiss-business-council
2022-03-14T20:04:09+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-provides-manufacturing-capabilities-support-global-covid-19-vaccines-tocilizumab-supply
2022-03-14T20:43:56+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-supports-icanserve-foundation-developing-breast-self-examination-video
2022-03-14T21:26:41+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-healthcare-philippines-recognized-country-certified-top-employer-2021
2022-03-14T20:33:35+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/global-patient-survey-reveals-gaps-axial-spondyloarthritis-management
2022-03-15T20:01:40+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/national-kidney-month-novartis-partners-promote-awareness-kidney-diseases-and-organ-donation
2022-03-15T15:03:56+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-hosts-region-first-asia-pacific-patient-innovation-summit-appis-commits-addressing-evolving-needs-patient-community
2022-03-15T20:07:41+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/filipinos-living-axial-spondyloarthritis-invited-participate-global-patient-survey
2022-03-15T19:59:52+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-contributions-ph-economy-health-care-highlighted-ph-switzerland-business-forum
2022-03-14T22:05:57+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-partner-organizations-carry-out-vision-screening-and-eye-health-education-several-provinces
2022-03-16T16:29:19+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/world-cml-day-doh-cml-alliance-philippines-novartis-celebrate-two-decades-medical-innovation-new-access-program-cml-patients
2022-03-25T21:42:31+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/doh-partners-icanserve-pha-novartis-promote-breast-cancer-awareness-through-patient-education-videos
2022-03-16T15:54:19+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-partners-raise-awareness-axspa-debilitating-spine-and-joint-disease
2022-03-14T16:34:23+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-supports-doh-goal-malaria-free-ph-2030
2022-03-14T17:41:20+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-healthcare-philippines-recognized-top-employer-second-consecutive-year
2022-03-25T21:44:53+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/iapb-perdami-ncsp-vrsp-fhf-novartis-join-forces-provide-eyecare-services-during-pandemic
2022-04-01T22:59:27+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/indonesia-philippines-vietnam-building-lessons-learned-enhance-eyecare-services-beyond-covid-19
2022-04-01T22:58:34+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/world-cancer-day-2022-novartis-committed-helping-close-gap-cancer-care
2022-04-01T22:57:17+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/survey-reveals-delayed-diagnosis-heavy-disease-burden-among-filipinos-axial-spondyloarthritis
2022-05-16T11:45:39+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-philippines-launches-pik3ca-testing-program-breast-cancer
2022-05-10T17:34:43+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/survey-reveals-heavy-disease-burden-psoriasis-among-filipinos
2022-06-23T15:09:18+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/philippine-fda-approves-novartis-advanced-breast-cancer-treatment-alpelisib
2022-07-13T11:22:00+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/breast-cancer-testing-to-improve-treatment-outcome
2022-08-15T11:40:16+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-ask-your-derm-ph-raise-awareness-pediatric-psoriasis-and-effective-treatments
2022-08-13T09:34:40+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/appis-announces-winners-inaugural-innovator-program
2022-08-19T19:26:04+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-hails-philippine-fda-approval-brolucizumab-treatment-age-related-macular-degeneration-time-sight-saving-month
2022-08-24T10:40:40+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/fda-appoves-riboclib-for-advanced-breast-cancer-in-males
2022-09-30T16:32:44+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-r-and-d-initiatives-contributions
2022-10-25T10:25:19+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-partners-doh-medical-societies-hospitals-strengthen-healthcare-system-and-improve-heart-failure-management-ph
2022-12-11T10:45:40+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-recognized-supporting-eye-health-services-amid-pandemic
2023-05-04T16:19:49+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/icanserve-taguig-city-dashlabs-novartis-launch-data-digital-project-support-breast-cancer-control-program
2023-01-20T13:51:10+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-healthcare-philippines-recognized-top-employer-third-consecutive-year
2023-01-20T13:51:28+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-associates-unblock-barriers-cardiovascular-health
2023-03-01T07:31:44+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-doh-and-partners-to-end-leprosy
2023-03-01T07:32:07+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-broadens-access-innovative-medicines-leverages-data-digital-enhanced-cancer-care-ph
2023-03-01T07:31:52+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/appis-2023-novartis-patient-leaders-hold-third-annual-regional-summit-accelerate-access-enhance-health-outcomes
2023-03-10T17:20:53+08:00
daily
0.5
https://www.novartis.com/ph-en/news/world-kidney-day-patient-groups-novartis-enhancing-health-access-renal-replacement-therapy-patients
2023-04-05T15:39:04+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/philippine-fda-approves-novartis-medicine-brolucizumab-treatment-visual-impairment-due-diabetic-macular-edema
2023-03-28T22:00:52+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-ribociclib-phase-iii-natalee-trial-shows-significant-benefit-patients-early-breast-cancer-interim-analysis
2023-04-11T06:27:30+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-medicine-ribociclib-prolongs-progression-free-survival-pre-and-perimenopausal-patients-aggressive-hrher2-metastatic-breast-cancer-compared-chemotherapy
2023-04-27T20:49:48+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-philippine-press-institute-icanserve-foundation-partner-media-workshop-enhance-breast-cancer-knowledge
2023-06-08T11:35:11+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-contributes-rebuilding-ph-post-pandemic-economy-strengthening-countrys-health-care-system
2023-06-10T00:30:38+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/inspiring-conversations-breast-cancer-roundtable-series-improve-survivorship-philippines
2023-07-27T12:00:34+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-philippines-launches-project-asp-ayoko-sa-plastic-reduce-plastic-footprint
2023-08-11T15:19:45+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-associates-check-their-cholesterol-levels-raise-awareness-heart-health
2023-10-20T13:39:46+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/screening-multistakeholder-collaboration-innovation-patient-centricity-keys-enhancing-breast-cancer-care
2023-09-26T23:35:57+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/public-private-sector-partnerships-vital-effective-and-sustainable-cancer-control-programs
2023-09-26T23:34:44+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/leadership-unified-multisectoral-efforts-needed-move-ph-breast-cancer-control-forward
2023-09-26T23:33:52+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/philippine-fda-approves-novartis-medicine-inclisiran-effective-cholesterol-management
2023-11-16T09:35:50+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/key-stakeholders-commit-work-together-addressing-barriers-breast-cancer-care-0
2024-01-25T13:43:47+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/enhance-patient-journey-hcpn-e-referral-through-stahr-initiative-collaboration-among-rizal-medical-center-thinking-machines-data-science-and-novartis-philippines
2024-01-12T10:11:23+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-supports-philippine-national-cancer-summit-empower-patients-and-enhance-breast-cancer-survivorship
2024-03-01T18:53:43+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/appis-2024-healthcare-stakeholders-come-together-prioritize-action-better-patient-outcomes-asia-pacific-middle-east-and-africa
2024-03-18T10:40:03+08:00
daily
0.5
https://www.novartis.com/ph-en/news/media-releases/novartis-session-philippine-national-cancer-summit-2024-highlights-key-role-patient-navigators-enhancing-breast-cancer-survivorship
2024-03-20T17:04:43+08:00
daily
0.5
https://www.novartis.com/ph-en/news/registration-2016-novartis-biocamp-now-open
2022-07-28T19:47:06+08:00
daily
1.0
https://www.novartis.com/ph-en/news/two-cum-laude-graduates-are-countrys-representatives-novartis-international-biocamp-switzerland
2022-03-15T15:02:10+08:00
daily
1.0
https://www.novartis.com/ph-en/news/novartis-supports-filipino-pulmonologists-call-improving-care-women-copd
2022-03-14T22:19:03+08:00
daily
1.0
https://www.novartis.com/ph-en/news/doh-novartis-foundation-renew-public-private-partnership-leprosy-control
2022-03-15T14:28:48+08:00
daily
1.0
https://www.novartis.com/ph-en/news/novartis-gathers-local-experts-filipino-mothers-highlight-womens-journey-adhd-alzheimers-disease-and-epilepsy
2022-03-14T22:25:31+08:00
daily
1.0
https://www.novartis.com/ph-en/news/sandoz-philippines-hosts-scientific-meeting-value-based-medicine-and-biosimilars-filipino-oncologists
2022-03-15T14:59:38+08:00
daily
1.0
https://www.novartis.com/ph-en/stories/building-science-and-innovation-nation
2022-04-06T20:37:38+08:00
daily
1.0
https://www.novartis.com/ph-en/stories/bamboo-spine-ankylosing-spondylitis
2022-03-15T14:54:45+08:00
daily
1.0
https://www.novartis.com/ph-en/stories/mental-health-migraine-and-workplace-culture-time-covid-19
2022-03-25T16:39:30+08:00
daily
1.0
https://www.novartis.com/ph-en/stories/asia-pacific-patient-innovation-summit-philippines-outcome-report-2021
2022-03-15T14:58:33+08:00
daily
1.0
https://www.novartis.com/ph-en/stories/novartis-supports-southeast-asian-breast-cancer-symposium
2022-09-26T08:45:18+08:00
daily
1.0
https://www.novartis.com/ph-en/stories/lowering-ldl-c-crucial-after-heart-attack-or-percutaneous-coronary-intervention
2023-11-13T16:44:36+08:00
daily
1.0